Teddy European Network of Excellence for Paediatric Research was funded in 2005 with the aim to favor the integration of the paediatric pharmacological research activities and contribute to the promotion of safe and efficacious medicines for children.
TEDDY is a Network of Excellence (NoE), strongly proactive in the promotion and implementation of adequate health policies and a social awareness on the importance of the paediatric medicines across Europe.
Today, TEDDY is an independent multidisciplinary, multinational Network composed of partners from more than 20 countries aimed at facilitating the performance of good quality paediatric studies and research.
TEDDY is a category 1 network member of Enpr-EMA, the European Network of Paediatric Research at the European Medicines Agency.
Moreover, TEDDY is member of Enpr-EMA Coordinating Group.
Any research centres and groups willing to be engaged in the development of clinical research can join the TEDDY Network. Find out more.
Covid-19
Are you a patient or a caregiver? Or do you want just to have clearer information about Covid-19?
Have a look at these Covid-19 Informative Fact Sheets.
Latest News
ESFRI Roadmap 2021: A new phase for the European Paediatric Translational Research Infrastructure
EPTRI the new establishing European Research Infrastructure entirely dedicated to paediatric research and coordinated by Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF), has successfully submitted the application to be included in the ESFRI
Annagrazia ALTAVILLA, Chair of TEDDY, appointed as consultant/expert of the Council of Europe for children focused activities foreseen in the new COE “Strategic Action Plan on Human Rights and Technologies in Biomedicine”
Annagrazia ALTAVILLA, Chair of TEDDY, has been appointed as consultant/expert of the Council of Europe - Bioethics Division, within the new DH -BIO Strategic Action Plan on Human Rights and Technologies in Biomedicine
